1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole has been researched along with hydroxychloroquine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, W; Jiang, L; Jing, Z; Pan, H; Sui, X; Xie, J; Yao, J; Zhou, Y | 1 |
1 other study(ies) available for 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and hydroxychloroquine
| Article | Year |
|---|---|
SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of the calcium/CaMKIIγ/AKT-mediated pathway.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Calcium Channel Blockers; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Proliferation; Colorectal Neoplasms; Cytochromes c; Dose-Response Relationship, Drug; Female; HCT116 Cells; HT29 Cells; Humans; Hydroxychloroquine; Imidazoles; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Proto-Oncogene Proteins c-akt; Time Factors; TOR Serine-Threonine Kinases; Transfection; Xenograft Model Antitumor Assays | 2016 |